246 related articles for article (PubMed ID: 19142184)
1. CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients.
Harder J; Engelstaedter V; Usadel H; Lassmann S; Werner M; Baier P; Otto F; Varbanova M; Schaeffner E; Olschewski M; Blum HE; Opitz OG
Br J Cancer; 2009 Jan; 100(2):360-5. PubMed ID: 19142184
[TBL] [Abstract][Full Text] [Related]
2. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
[TBL] [Abstract][Full Text] [Related]
3. Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay.
Lotspeich E; Schoene M; Gerngross H; Schmidt R; Steinmann R; Ramadani M; Gansauge S
Langenbecks Arch Surg; 2007 Sep; 392(5):559-66. PubMed ID: 17457603
[TBL] [Abstract][Full Text] [Related]
4. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
5. Septin 9 methylation analysis of lymph node micrometastases for predicting relapse of colorectal cancer.
Wan Y; Liang JJ; Luo XJ; Zhu XJ; He JL; Wang SB; Zhao YY; Zeng D; Zhang L; Tang XK
Ann Diagn Pathol; 2022 Oct; 60():152021. PubMed ID: 35939880
[TBL] [Abstract][Full Text] [Related]
6. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Bilchik AJ; Saha S; Wiese D; Stonecypher JA; Wood TF; Sostrin S; Turner RR; Wang HJ; Morton DL; Hoon DS
J Clin Oncol; 2001 Feb; 19(4):1128-36. PubMed ID: 11181678
[TBL] [Abstract][Full Text] [Related]
7. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
[TBL] [Abstract][Full Text] [Related]
8. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-Specific SHP1-P2 Methylation - a Novel Universal Tumor Marker for Detection of Colorectal Cancer Lymph Node Metastasis.
Rattanatanyong P; Keelawat S; Kitkumthorn N; Mutirangura A
Asian Pac J Cancer Prev; 2016; 17(8):4117-23. PubMed ID: 27644671
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
Tu XH; Huang SX; Li WS; Song JX
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
[TBL] [Abstract][Full Text] [Related]
11. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
12. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
13. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
15. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.
Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y
Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782
[TBL] [Abstract][Full Text] [Related]
16. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression.
Lassmann S; Bauer M; Rosenberg R; Nekarda H; Soong R; Rüger R; Höfler H; Werner M
Int J Colorectal Dis; 2004 Mar; 19(2):87-94. PubMed ID: 13680284
[TBL] [Abstract][Full Text] [Related]
17. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.
Noura S; Yamamoto H; Ohnishi T; Masuda N; Matsumoto T; Takayama O; Fukunaga H; Miyake Y; Ikenaga M; Ikeda M; Sekimoto M; Matsuura N; Monden M
J Clin Oncol; 2002 Oct; 20(20):4232-41. PubMed ID: 12377967
[TBL] [Abstract][Full Text] [Related]
18. The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence.
Vinayanuwattikun C; Chantranuwat P; Sriuranpong V; Mutirangura A
Int J Clin Oncol; 2014 Aug; 19(4):586-92. PubMed ID: 23824557
[TBL] [Abstract][Full Text] [Related]
19. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
